日本-话题@MedSci

#日本#

594篇内容 | 8319人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294615, encodeId=36161294615e4, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=直播推荐 | 老龄少子，照护难题怎么办？日本知名专家铃木知佐子来解读, objectType=article, longId=211795, objectId=fe5d211e952d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe5d211e952d, replyNumber=0, likeNumber=64, createdTime=2021-05-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe5d211e952d, moduleTitle=直播推荐 | 老龄少子，照护难题怎么办？日本知名专家铃木知佐子来解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe5d211e952d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294614, encodeId=a3ea1294614dc, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Am J Gastroenterology：体重增加对日本非肥胖人群非酒精性脂肪肝发病率的影响, objectType=article, longId=210397, objectId=94fd21039e90, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94fd21039e90, replyNumber=0, likeNumber=81, createdTime=2021-04-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94fd21039e90, moduleTitle=Am J Gastroenterology：体重增加对日本非肥胖人群非酒精性脂肪肝发病率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94fd21039e90)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294613, encodeId=73fa129461377, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=个人每年辐射剂量计算器-再也不用担心日本核辐射了, objectType=article, longId=210036, objectId=aff421003698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aff421003698, replyNumber=0, likeNumber=29, createdTime=2021-04-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aff421003698, moduleTitle=个人每年辐射剂量计算器-再也不用担心日本核辐射了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aff421003698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294611, encodeId=3b851294611f1, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=关于日本核废水将“辐射”全球这件事，美国双标又来了！, objectType=article, longId=210009, objectId=304c21000969, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=304c21000969, replyNumber=0, likeNumber=119, createdTime=2021-04-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=304c21000969, moduleTitle=关于日本核废水将“辐射”全球这件事，美国双标又来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=304c21000969)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294612, encodeId=cfe1129461211, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=深度 | 日本核废水将“辐射”全球，或将成为继新冠以来又一全球公共卫生危机?, objectType=article, longId=209966, objectId=2f232099667c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f232099667c, replyNumber=0, likeNumber=75, createdTime=2021-04-16, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f232099667c, moduleTitle=深度 | 日本核废水将“辐射”全球，或将成为继新冠以来又一全球公共卫生危机?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f232099667c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294610, encodeId=18f21294610f6, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本政府正式决定：倾倒百万吨核废水入海，人类或将面临“灭顶之灾”！, objectType=article, longId=209931, objectId=1ea0209931fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ea0209931fa, replyNumber=0, likeNumber=100, createdTime=2021-04-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ea0209931fa, moduleTitle=日本政府正式决定：倾倒百万吨核废水入海，人类或将面临“灭顶之灾”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ea0209931fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294609, encodeId=8708129460912, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本政府机构称该国正进入“第四波”疫情, objectType=article, longId=209393, objectId=3cc52093934c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cc52093934c, replyNumber=0, likeNumber=0, createdTime=2021-04-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cc52093934c, moduleTitle=日本政府机构称该国正进入“第四波”疫情, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cc52093934c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294608, encodeId=c1041294608ba, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本厚生劳动省批准CAR-T细胞疗法Breyanzi治疗DLBCL和滤泡性淋巴瘤, objectType=article, longId=209158, objectId=40ec209158b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ec209158b9, replyNumber=0, likeNumber=70, createdTime=2021-03-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ec209158b9, moduleTitle=日本厚生劳动省批准CAR-T细胞疗法Breyanzi治疗DLBCL和滤泡性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40ec209158b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294607, encodeId=c276129460eb9, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=CureApp与自治医科大学合作开发高血压治疗app：日本III期临床试验达到主要终点, objectType=article, longId=208907, objectId=e5a320890ef2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5a320890ef2, replyNumber=0, likeNumber=72, createdTime=2021-03-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5a320890ef2, moduleTitle=CureApp与自治医科大学合作开发高血压治疗app：日本III期临床试验达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5a320890ef2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294606, encodeId=d2e2129460671, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=来自日本的Nichi葡聚糖膳食补剂有望用作COVID-19疫苗佐剂, objectType=article, longId=208238, objectId=7a93208238dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a93208238dc, replyNumber=0, likeNumber=66, createdTime=2021-03-12, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a93208238dc, moduleTitle=来自日本的Nichi葡聚糖膳食补剂有望用作COVID-19疫苗佐剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a93208238dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294605, encodeId=69d31294605d0, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本上千剂疫苗报废，供电不足致冷冻箱发生故障, objectType=article, longId=208061, objectId=e56120806174, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e56120806174, replyNumber=0, likeNumber=68, createdTime=2021-03-08, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e56120806174, moduleTitle=日本上千剂疫苗报废，供电不足致冷冻箱发生故障, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e56120806174)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294604, encodeId=db9612946042f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=病毒RNA聚合酶抑制剂AT-527治疗COVID-19，Chugai制药公司将负责日本的开发和销售, objectType=article, longId=207374, objectId=789020e3747d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=789020e3747d, replyNumber=0, likeNumber=72, createdTime=2021-02-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=789020e3747d, moduleTitle=病毒RNA聚合酶抑制剂AT-527治疗COVID-19，Chugai制药公司将负责日本的开发和销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=789020e3747d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294603, encodeId=e55c12946038f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Dig Dis Sci:血清球蛋白与日本溃疡性结肠炎患者的内窥镜检查结果和粘膜愈合有关, objectType=article, longId=207200, objectId=75f720e2004f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75f720e2004f, replyNumber=0, likeNumber=68, createdTime=2021-02-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75f720e2004f, moduleTitle=Dig Dis Sci:血清球蛋白与日本溃疡性结肠炎患者的内窥镜检查结果和粘膜愈合有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75f720e2004f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294602, encodeId=8c42129460269, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本药企小林化工造假达40年！小林退热贴还能用么？能！, objectType=article, longId=207059, objectId=7cef20e05913, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cef20e05913, replyNumber=0, likeNumber=93, createdTime=2021-02-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cef20e05913, moduleTitle=日本药企小林化工造假达40年！小林退热贴还能用么？能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cef20e05913)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294601, encodeId=0d061294601b1, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本药企小林化工造假达40年！现已被勒令停业整顿，500种药品80%有造假记录, objectType=article, longId=207056, objectId=19cc20e056f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19cc20e056f3, replyNumber=0, likeNumber=66, createdTime=2021-02-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19cc20e056f3, moduleTitle=日本药企小林化工造假达40年！现已被勒令停业整顿，500种药品80%有造假记录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19cc20e056f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294600, encodeId=eb6112946009e, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=JAMA Netw Open：新冠期间日本自杀率涨幅明显, objectType=article, longId=206800, objectId=9f4c2068002d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f4c2068002d, replyNumber=0, likeNumber=78, createdTime=2021-02-06, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f4c2068002d, moduleTitle=JAMA Netw Open：新冠期间日本自杀率涨幅明显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f4c2068002d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294599, encodeId=7825129459978, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=YESCARTA在日本获批用于治疗复发难治大B细胞淋巴瘤（DLBCL）, objectType=article, longId=206207, objectId=df2920620e11, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2920620e11, replyNumber=0, likeNumber=0, createdTime=2021-01-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2920620e11, moduleTitle=YESCARTA在日本获批用于治疗复发难治大B细胞淋巴瘤（DLBCL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2920620e11)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294598, encodeId=229e129459869, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗, objectType=article, longId=206188, objectId=8ad420618870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad420618870, replyNumber=0, likeNumber=93, createdTime=2021-01-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad420618870, moduleTitle=日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ad420618870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294597, encodeId=df5e129459e49, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本厚生劳动省（MHLW）批准α-1蛋白酶抑制剂Lynspad治疗α-1抗胰蛋白酶缺乏症, objectType=article, longId=206186, objectId=022b2061861a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022b2061861a, replyNumber=0, likeNumber=209, createdTime=2021-01-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022b2061861a, moduleTitle=日本厚生劳动省（MHLW）批准α-1蛋白酶抑制剂Lynspad治疗α-1抗胰蛋白酶缺乏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022b2061861a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294596, encodeId=8f3712945960d, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本音乐家坂本龙一确诊直肠癌！八成患者确诊直肠癌已是中晚期, objectType=article, longId=206004, objectId=f4d82060042a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4d82060042a, replyNumber=0, likeNumber=83, createdTime=2021-01-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4d82060042a, moduleTitle=日本音乐家坂本龙一确诊直肠癌！八成患者确诊直肠癌已是中晚期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4d82060042a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

日本

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#日本#

直播推荐 | 老龄少子，照护难题怎么办？日本知名专家铃木知佐子来解读

2021-05-27

chentianping (审核中...)

前往app查看评论内容

#日本#

Am J Gastroenterology：体重增加对日本非肥胖人群非酒精性脂肪肝发病率的影响

2021-04-25

chentianping (审核中...)

前往app查看评论内容

#日本#

个人每年辐射剂量计算器-再也不用担心日本核辐射了

2021-04-17

chentianping (审核中...)

前往app查看评论内容

#日本#

关于日本核废水将“辐射”全球这件事，美国双标又来了！

2021-04-17

chentianping (审核中...)

前往app查看评论内容

#日本#

深度 | 日本核废水将“辐射”全球，或将成为继新冠以来又一全球公共卫生危机?

2021-04-16

chentianping (审核中...)

前往app查看评论内容

#日本#

日本政府正式决定：倾倒百万吨核废水入海，人类或将面临“灭顶之灾”！

2021-04-15

chentianping (审核中...)

前往app查看评论内容

#日本#

日本政府机构称该国正进入“第四波”疫情

2021-04-04

chentianping (审核中...)

前往app查看评论内容

#日本#

日本厚生劳动省批准CAR-T细胞疗法Breyanzi治疗DLBCL和滤泡性淋巴瘤

2021-03-31

chentianping (审核中...)

前往app查看评论内容

#日本#

CureApp与自治医科大学合作开发高血压治疗app：日本III期临床试验达到主要终点

2021-03-25

chentianping (审核中...)

前往app查看评论内容

#日本#

来自日本的Nichi葡聚糖膳食补剂有望用作COVID-19疫苗佐剂

2021-03-12

chentianping (审核中...)

前往app查看评论内容

#日本#

日本上千剂疫苗报废，供电不足致冷冻箱发生故障

2021-03-08

chentianping (审核中...)

前往app查看评论内容

#日本#

病毒RNA聚合酶抑制剂AT-527治疗COVID-19，Chugai制药公司将负责日本的开发和销售

2021-02-22

chentianping (审核中...)

前往app查看评论内容

#日本#

Dig Dis Sci:血清球蛋白与日本溃疡性结肠炎患者的内窥镜检查结果和粘膜愈合有关

2021-02-18

chentianping (审核中...)

前往app查看评论内容

#日本#

日本药企小林化工造假达40年！小林退热贴还能用么？能！

2021-02-13

chentianping (审核中...)

前往app查看评论内容

#日本#

日本药企小林化工造假达40年！现已被勒令停业整顿，500种药品80%有造假记录

2021-02-13

chentianping (审核中...)

前往app查看评论内容

#日本#

JAMA Netw Open：新冠期间日本自杀率涨幅明显

2021-02-06

chentianping (审核中...)

前往app查看评论内容

#日本#

YESCARTA在日本获批用于治疗复发难治大B细胞淋巴瘤（DLBCL）

2021-01-26

chentianping (审核中...)

前往app查看评论内容

#日本#

日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗

2021-01-26

chentianping (审核中...)

前往app查看评论内容

#日本#

日本厚生劳动省（MHLW）批准α-1蛋白酶抑制剂Lynspad治疗α-1抗胰蛋白酶缺乏症

2021-01-26

chentianping (审核中...)

前往app查看评论内容

#日本#

日本音乐家坂本龙一确诊直肠癌！八成患者确诊直肠癌已是中晚期

2021-01-23

科室
- - 订阅+
  - 更多科室
工具
服务